Child Mortality
10
0
2
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
30%
3 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (10)
Improving Care Through Azithromycin Research for Infants in Africa
Infant Mortality Reduction by the Mass Administration of Azithromycin
REACH2: Implementation Research on Bi-Annual Mass Distribution of Azithromycin to Children 1-11 Months in Côte d'Ivoire
A Second Dose of Measles Vaccine (MV) in the Second Year of Life
MORDOR II Burkina Faso: Longitudinal Trial
Resiliency Through Azithromycin for Children (REACH), Côte d'Ivoire
South African Paediatric Surgical Outcomes Study (SAPSOS)
Birth Cohort in Rahimyar Khan, Pakistan
MNCH Programming in Southwest Uganda Maternal and Child Health In Bushenyi and Rubirizi Districts, UGANDA
Community-Based Interventions for Infant Health in Nepal